We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Brain Cancer

Journal Scan / Research · April 14, 2021

RT, RT + TMZ, or TMZ for Newly Diagnosed 1p/19q Codeleted Oligodendroglioma



Additional Info

Disclosure statements are available on the authors' profiles:

CODEL: Phase III Study of RT, RT + TMZ, or TMZ for Newly Diagnosed 1p/19q Codeleted Oligodendroglioma. Analysis From the Initial Study Design
Neuro-oncology 2021 Mar 25;23(3)457-467, KA Jaeckle, KV Ballman, M van den Bent, C Giannini, E Galanis, PD Brown, RB Jenkins, JG Cairncross, W Wick, M Weller, KD Aldape, JG Dixon, SK Anderson, JH Cerhan, JS Wefel, M Klein, SA Grossman, D Schiff, JJ Raizer, F Dhermain, DG Nordstrom, PJ Flynn, MA Vogelbaum

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading